ProfileGDS4132 / 1556242_a_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 46% 45% 47% 42% 50% 49% 44% 55% 39% 43% 25% 23% 29% 31% 20% 26% 33% 39% 31% 31% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101122.69246
GSM201543Muscle PCOS pioglitazone 121110.40845
GSM201544Muscle PCOS pioglitazone 161126.1147
GSM201545Muscle PCOS pioglitazone 201118.48942
GSM201829Muscle PCOS pioglitazone 231141.10550
GSM201830Muscle PCOS pioglitazon 251137.44949
GSM201831Muscle PCOS pioglitazone 271115.02244
GSM201832Muscle PCOS pioglitazone 31144.28155
GSM201833Muscle PCOS pioglitazone 4193.477639
GSM201834Muscle PCOS pioglitazone 81110.58843
GSM201835Muscle PCOS after pioglitazone 10246.493925
GSM201836Muscle PCOS after pioglitazone 12244.759623
GSM201837Muscle PCOS after pioglitazone 16258.724529
GSM201838Muscle PCOS after pioglitazone 20267.257931
GSM201839Muscle PCOS after pioglitazone 23239.513720
GSM201840Muscle PCOS after pioglitazone 25258.479826
GSM201841Muscle PCOS after pioglitazone 27267.838133
GSM201842Muscle PCOS after pioglitazone 3282.490839
GSM201843Muscle PCOS after pioglitazone 4274.784931
GSM201844Muscle PCOS after pioglitazone 8269.802131